Functional screening implicates miR-371-3p and peroxiredoxin 6 in reversible tolerance to cancer drugs
Acquired resistance significantly limits the efficacy of cancer drug therapies. Here, the authors identify miR-371-3p as a suppressor of drug tolerance in cancer cell lines by its target gene PRDX6, which in turn regulates PLA2/PKCα signalling and ROS levels.
Guardado en:
Autores principales: | Nisebita Sahu, Jean-Philippe Stephan, Darlene Dela Cruz, Mark Merchant, Benjamin Haley, Richard Bourgon, Marie Classon, Jeff Settleman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/01cff8d056c9437f9bb6381d87492a43 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Acta Nº371
por: Banco Central de Chile
Publicado: (2019) -
Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study
por: Mette Pernille Myklebust, et al.
Publicado: (2021) -
Children’s screen time alters the expression of saliva extracellular miR-222 and miR-146a
por: Annette Vriens, et al.
Publicado: (2018) -
Chronic administration of proanthocyanidins or docosahexaenoic acid reverses the increase of miR-33a and miR-122 in dyslipidemic obese rats.
por: Laura Baselga-Escudero, et al.
Publicado: (2013) -
Circulating miR-30a-5p and miR-182-5p in Prediabetes and Screen-Detected Diabetes Mellitus
por: Weale CJ, et al.
Publicado: (2020)